Adopting parents who choose a child with a disease listed below will be allowed the right to adopt sick children without a waiting period of being on the "list of registration" in the Center of Adoption, (attached to the ministry of Education of Ukraine) Listed here by: Nosology/Denomination of Nosology/Code of Nosologic units corresponding to the International classification of diseases X revision/Denomination of diseases.

(This is taken from a literally translated Ukrainian list)

CLASS OF DISEASES (NOSOLOGY)

GROUP II NEOPLASMS/TUMORS

• C-37 Malignant Neoplasm of Thymus gland (Operable Surgery) --- Malignant (Cancerous tumor) - Neoplasm (new growth of tissue), lymphoid tissue, T-Cells develop, Upper anterior chest/or at the base of the neck.

• C-46 Kaposis' Sarcoma (Operable Surgery)- Viral origin, skin and mucous membranes affecting esp.

• C-51-C-57 Malignant Neoplasm of female genital organs (Operable Surgery) --- cancerous tumor of.

• C-69-C-72 Malignant Neoplasm of eye, brain and other parts of the Central nervous system (Operable Surgery Possible)

• C-73-C-75 Malignant Neoplasm of thyroid (Large Endocrine Gland at the Base of the Neck)and other endocrine glands (Operable Surgery) -Cancerous Tumor , integrate and control metabolic (bodily) activity, pituitary, thyroid, etc.

• C-81 Crowfoot Hodgkin's diseases (medication - good response) - Neoplastic Disease, Progressive enlargement of lymph nodes, spleen, and liver and progressive anemia

• C-82-C-83 Non-hodgkin lymphomas (medication - good response)

• C-85 Other and non-identified types of non-Hodgkin lymphomas (medication)

• C-88 Malignant immunoproliferative diseases - Cancer Tumor - relating to or characterized by the production of abnormally increased numbers of antibody producing cells.

• C-90 Multiples myeloma and malignant plasmocellural (cancerous) neoplasmas -- Primary tumor of the bone marrow.

• C-91 Myeloid Leukemia (Chemotherapy - fair success rate) - Relating to or resembling Bone Marrow, Relating to Spinal Cord increase in white blood cells blood forming organs.

• C-92 Lymphoid Leukemia (Chemotherapy - fair success rate) - Lymph nodes or thymus - abnormal increase of leokocytes (white or colorless cell), in the circulating blood, and enlargement of lymph nodes.

• C-93 Monocytic Leukemia - large numbers in circulating blood, large phagocytic leukocyte.

• C-94 Other Leukemia of specified cellural type (Chemotherapy - fair success rate).

• C-95 Leukemia of non-specified type (Chemotherapy - fair success rate)

• C-96 Other and unspecified malignant (cancers) neoplasmas of lymphoid himopoietic and allied tissue (Chemotherapy or possible surgery) - Formation of blood or blood cells in the living body.

• C-97 Malignant neoplasmas of independant/primary/multiplex localization (Chemotherapy or possible surgery - not optimistic).

GROUP III DISEASES OF BLOOD AND HEMOPOIETIC ORGANS AND SEPARATE DISTURBANCES INCLUDING IMMUNE MECHANISM

• D-55 Anemia (blood deficient in red blood cells) due to the disturbances of enzymes (medication) Hemoglobin or in total volume.

• D-56 Thalassemia/Cooleys anemia, thalassanemia - reduction in or failure of synthesis of one of the globin chains making up hemoglobin (oxygen from lungs to tissues of body) resulting in deficiency.

• D-57 Sickle cell Trait (bone marrow transplant - fair success rate) -- abnormal blood cell, excessive destruction of red blood cells.

• D-58 Other hereditary hemolytic anemia (medication possible) - caused by chemical poisoning , infection, sickle cell.

• D-60 Erythroblastopenia (Surgery - fair success rate) - abnormal number of a cell of ancestral to red blood cells.

• D-61 Other aplastic anemia (medications) - not exhibiting growth or change in structure.

• D-66 Hereditary insufficiency of factor VIII/anti-hemophilic factor (transfusion - poor) - glco protein of blood plasma that is essential for blood clotting and is absent or inactive in hemophilia (sex linked hereditary blood defect) almost exclusively male - delay of clotting of the blood - subsequent difficulty controlling hemorrhage even after minor injuries.

• D-67 Hereditary insufficiency of factor IX plasma thromboplastic component (initiating or accelerating the clotting of the blood) (trans-poor) - clotting factor associated with Christmas Disease (hereditary sex linked hemorrhage disease) involving absence of a coagulation factor in the blood and the failure of the clotting mechanism.

• D-68 Other disturbances connected with blood coagulation (process of becoming viscous or thickened into a coherent mass) (medication - extreme caution).

• D-69 Purpura and other hemorrhagic conditions (medication - extreme caution) - unknown cause - bleeding into the skin with production of petechiae (reddish or purplish spot containing blood) appears in skin or mucous membrane.

• D-70 Agrunolocytosis (Lethal - Possible medication) - Acute febrile condition marked by severe depression of the granulocyte - producting bone marrow and by prostration, chills, swollen neck, and sore throat - basically a response to the side effects of certain drugs.

• D-74 Methemoglobinemia (lethal - possible medication) - the presence of methemoglobin (a soluble brown crystalline basic blood pigment that is found in normal blood in much small amounts than hemoglobin) in the blood due to conversion of part of the hemoglobin to this (inactive) form.

• D-86 Sarcoidosis -- A chronic disease of unknown caus that is characterized by the formation of nodules resembling true turbercles esp. in the lymph nodes, lungs, bones and skin.

GROUP IV ENDOCRINE DISEASES, DISTURBANCES OF FEEDING AND METABOLISM

• E-02-E-06 Disturbances of the thyroid gland (medication) large endocrine gland lies in the base of the neck, produces iodine containing hormone - influences growth and development.

• E-10-E-14 Diabetes mellitus (medication) - Variable disorder of carbohydrate metabolism caused by combination of hereditary and environmental factors, characterized by inadequate secretion or utilization of insulin.

• E-20 Hypoparathyrosis (Medication) - Deficiency of parathormone (hormone of parathyroid gland concerned ie. calcium utilization in the body) body also resultant abnormal state by low serum calcium and a tendency to chronic tetany (abnormal calcium metabolism).

• E-21 Hypoparathyrosis and other disturbances of the para-thyroid gland (medication).

• E-22 Hyperfunction (excessive or abnormal activity of pituitary) of pituitary body (medication) -- attached to the infundibulum (any of various conical or dilated organs or parts) of the brain - endocrine organ - several parts are associated with various hormones.

• E-23 Hyperfunction and other disturbances of pituitary body (medication).

• E-25 Adrenogenital disturbances (medication) - Cushings Syndrome - A disease characterized by obesity and muscular weakness - associated with the excessive production of cortisol - due to adrenal or pituitary dysfunction.

• E-26 HyperAldosteronism (medication) - excessive production and excretion of adiosterone and typically by loss of body potassium, muscular weakness, and elevated blood pressure.

• E-27 Other disturbances of functioning of Adrenal gland (Surgery or medication).

• E-31 Polyglandular (involving several glands) dysfunction (sometimes surgery).

• E-70 Disturbances of aromatic amino acid metabolism (medication) - smell or odor - organic acid containing amino group.

• E-71 Disturbances of amino acid metabolism chain and disturbances of fatty acid metabolism (Diet or medication).

• E-72 Other disturbances of amino acid metabolism.

• E-73 Lactose intolerance (easily treated and diet) - A disaccharide sugar that is present in milk - not tolerant of.

• E-74 Other disturbances of carbohydrate metabolism (special diet) - sugars, starches, and celluloses most of which are formed by green plants and which constitute a major class of animal foods.

• E-75 Disturbances of sphin-golipides metabolism and other disturbances in lipoids accumulation (medication) - any of a group of lipids that yield sphingosine (unsaturated amino diol) or one of its derivatives - lipoids (resemble fat).

• E-76 Disturbances of glycosamine-glycanes metabolism (medication) - any of a class of polysaccharides that are widely distributed in the body that bind water to form thick gelatinous serving to cement cells together and to lubricate joints.

• E-77 Disturbances of glycoprotien (a conjugated protein in which the nonprotein group is a carbohydrate) metabolism (medication).

• E-78 Disturbances of lipoprotein metabolism and other lipidemia (medication) - any of a large class of conjugated proteins composed of a complex of protein and lipid and seperable on the basis of solubility and mobility properties.

• E-79 Disturbances of purine and pyrimidine metabolism (medication) - a crystalline base that is the parent of the uric acid group - a base that is a consistuent of DNA or RNA and a feeble organic base of penetrating odor.

• E-80 Disturbances of porphyrin and bilirubin metabolism (medication) - any of various compounds with a structure that consists essentially of four pyrrole ring joinedr by 4 groups and a reddish yellow pigment that occurs esp. in bile and blood and causes jaundice if accumulated in excess.

• E-84 Cystic fibrosis (medication) - a common hereditary disease esp. in caucasian populations that appears usually in early childhood, involves generalized disorder of exocrine glands, and is marked esp. by the faulty digestion due to a deficiency of pancreatic enzymes by difficulty in breathing, and by excess in the sweat.

• E-85 Amyloidosis - A condition characterized by the deposition of amyilyoid (a non nitrogenous starchy food) in organs or tissues of the animal body.

GROUP V DISTURBANCES OF PSYCHIS AND BEHAVIOR

• F-73 Deep mental retardation (Very Poor outlook - No treatment)

• F-90 Hyperkinetic deficiencies (disturbances) (Sometimes medication - outlook poor) - abnormal increased and sometimes uncontrollable activity of muscular movements.

GROUP VI DISEASES OF THE NERVOUS SYSTEM

• G-40 Epilepsy (Medication) - any of the various disorders marked by disturbed electrical rhythms of the central nervous system and typically manifested by convulsive attacks usually with clouding of central consciousness.

• G-50-59 Lesion (injury) of nerves, nerve roots and plexus (a network of anastomosing or interlacing blood vessels or nerves) ( Surgery).

• G-80-83 Cerebral paralysis and other paralytic syndromes (Medication - Outlook Poor) - Cerebral of or relating to brain or intellect - complete or partial loss of function.

GROUP VIII DISEASES OF EAR AND PAPILLIFORM PROCESS (OUTGROWTH)

• H-90 Conductive and neuro-sensory hearing loss (Surgery - Maybe) - Failure in the mechanisms for sound transmission of sound waves to the organ of corti conductive deafness and nerve hearing loss.

• H-91 Other hearing loss (Depends on Damage)

GROUP IX DISEASES OF BLOOD CIRCULATION

• I-05 Rheumatic diseases of mitral valve (medication) -- inflammation and pain of the valve in the heart that guards the opening between the left atrium and the left ventricle.

• I-06 Rheumatic diseases of aortic valve (medication) -- the semilunar valve separating the aorta from the left ventricle that prevents blood from flowing back into the left ventricle.

• I-07 Rheumatic diseases of tricuspid valve (medication) a valve that is situated at the opening of the right atrium of the heart into the right ventricle.

• I-08 Lesions (injuries) of several valves (medication).

GROUP X DISEASES OF RESPIRATORY SYSTEM

• J-45 Asthma (medication) - a condition often of a allergic origin that is marked by continous or labored breathing accompanied by wheezing, coughing, and gasping.

• J-47 Bronchectasis (medication) -- chronic inflammatory or degenerative condition of one or more bronchi or bronchioles marked by dilatation and loss of elasticity of the walls.

GROUP XI DISEASES OF THE DIGESTIVE SYSTEM

• K-51 Ulcerative colitis (medication) - A break in the skin or mucous membrane with loss of surface tissue (inflammation of the colin).

• K-73 Chronic hepatitis which was not classified in other columns - Inflammation of the liver.

• K-74 Fibrosis and cirrhosis of the liver -- Condition marked by increase of interstitial fibrous tissue and hardening caused by excessive formation of connective tissue followed by contraction.

GROUP XII SKIN DISEASES AND DISEASES OF HYPODERMIC CELL

• L-10 Pemphigus vulgaris (medication or surgery possible) - severe often fatal form of chronic, any of several diseases characterized by the formation of successive crops of large blisters on apparently normal skin, and mucous membranes often in association with sensations of itching or burning and with constitutional symptoms.

• L-11 Other acantholytic disturbances (medication or surgery) - a benign overgrowth of the prickle-cell layer of the skin.

• L-12 Pemphigod (medication or surgery possible) - several diseases that resemble pemphigus.

• L-13 Other bullouss (lesions) disturbances (medication or surgery possible) - chronic skin diseases - numerous hard blisters over a wide spread area.

• L-14 Bullous disturbance within diseases classified in other columns (medication or surgery possible).

GROUP XIII DISEASES OF OSTEO-MUSCULAR SYSTEM AND CONNECTIVE TISSUE

• M-30 Nodosal (knotted) polyarthritis and connective positions - arthritis involving two or more joints.

• M-31 Other necrotizing vasulopatia - death of a living tissue; death of portion of tissue differentially affected by local injury (as loss of blood supply, corrosion, burning or the local lesion of a disease).

• M-32 Systemic lupis erythematous -- Relating to a characterization of skin inflammation.

• M-33 Dermatopolymiositis -- A fungus parasitic upon the skin or skin derivatives (as hair or nails).

• M-35 Other systemic lesion (injuries) of connective tissue within diseases classified in other columns.

• M-81 Osteoporosis without pathologic fracture -- a disease that is characterized by decrease in bone mass with decreased density and enlargement of bone spaces producing porosity and fragility and that results from disturbance of nutrition and mineral metabolism.

• M-88 Paget's disease (osteitus deformans) -- an eczematous (eczema - inflammatory condition of the skin with redness, itching and oozing vesicular lesions) precancerous condition esp. of the nipple and areola, a chronic disease of bones characterized by their great enlargement and rarefaction with bowing of the long bones and deformation of the flat bones.

GROUP XIV DISEASES OF THE GENITOURINARY SYSTEM

• N-03 Chronical nephrotic syndrome - a non-inflammatory disease of the kidneys chiefly affecting function of the nephrons.

• N-04 Nephrotic syndrome -- a abnormal condition that is marked by deficiency of albumin in the blood and its excretion in the urine due to altered permeability of the glomerular (a small convoluted or intertwined mass as of organisms, nerve fibers, or capilliaries) basement membranes (as by a toxic chemical agent).

• N-05 Unspecified nephrotic syndrome - related to or affected by or associated with nephrosis.

GROUP XVII HEREDITARY INSUFFICIENCY OF DEVELOPMENT (UNDERDEVELOPMENT) DEFORMATIONS AND CHROMOSOMAL ANOMALIES

• Q-02 Microcephaly - a condition of abnormal smallness of the head usu. Associated with mental defects.

• Q-05 Fissure (cleft, aperture) of the vertebral column - a natural cleft between body parts (break or slit) of the spinal column.

• Q-20-28 Hereditary insufficiency of the development of blood circulation system.

• Q-35-37 Cleft lip and cleft palate ( roof of the mouth separating the mouth from the nasal cavity) - abnormal fissue or opening of the lip or esp. when resulting from failure of parts to fuse during embryonic development.

• Q-77 Osteochondrodysplasia with defects of growing tubular bones and vertebra column - abnormal growth or development of cartilage and bone.

• Q-80 Hereditary ichthyosis / ichthyosis congenita -- (existing or dating from birth) ecze